Nuwellis receives patent approval for dual lumen midline catheter technology

Go back to Nuwellis receives patent approval for dual lumen midline catheter technology
(NASDAQ: NUWE) Delayed: 0.13 --0 (-0%)
Previous Close $0.13    52 Week High
Open $0.13    52 Week Low
Day High $0.13    P/E N/A 
Day Low $0.13    EPS
Volume 17,457